Skip to content

Caelus Pharmaceuticals B.V.

Ongoing bankruptcy
1 financial report
KvK
60107383
Establishment
Zegveld, Utrecht
Court
Amsterdam
Bankruptcy number
F.13/25/78
Judgment
March 4, 2025
Insolvency practitioner
mr. J.F.H.M. Bartels, Labré Advocaten

Summary

On March 4, 2025, the Rechtbank Amsterdam declared Caelus Pharmaceuticals B.V. bankrupt (insolvency number F.13/25/78). It is a BV from Zegveld (Utrecht). Its KvK number is 60107383. According to the Commercial Register, its main activity is medische laboratoria, trombosediensten en overig behandelingsondersteunend onderzoek. mr. J.F.H.M. Bartels (Labré Advocaten) has been appointed insolvency practitioner. mr. J.B. Oreel has been appointed supervisory judge. There is 1 public report, dated November 16, 2026. In addition, there is 1 financial report, dated November 16, 2026. Estate assets according to financial report 7: €286,575.99. Key figures according to report 7: unsecured claims €4,922,953.29, creditors 19 en preferential claims €773,908.17. Causes of the bankruptcy according to report 7: completed.

Utrecht recorded 247 bankruptcies in the past twelve months. Of these, 8 came from the municipality of Woerden.

Employees according to report 7 of November 16, 2026: 4.

The company information lists Rondweg 50, 3474KG Zegveld as a business address for Caelus Pharmaceuticals B.V..

On March 5, 2025, the Dutch Insolvency Register published: “Uitspraak faillissement op 04 maart 2025”

Submit a claim

Creditors submit their claim in writing to the insolvency practitioner, stating insolvency number F.13/25/78 and enclosing the supporting documents.

Deadline for submission
Not published
Estate assets Fin. report 7
€286,575.99, history of Estate assets
Unsecured claims Report 7
€4,922,953.29, history of Unsecured claims
Preferential Report 7
€773,908.17, history of Preferential
Creditors Report 7
19, history of Creditors
Employees Report 7
4, history of Employees

Further case information

Status

Rent and lease
Mentioned Rent and lease
Causes of the bankruptcy
Completed Causes of the bankruptcy
De bestuurder heeft verklaard dat de aandeelhouders in maart 2024 een overeenkomst hebben gesloten waarbij zij hun aandelen hebben verkocht aan een investeerder uit de Verenigde Arabische Emiraten, waarbij die investeerder tevens financiering aan de vennootschap zou verstrekken voor de verdere ontwikkeling en vermarkting van het product. Tot overdracht van de aandelen is het echter niet gekomen, o
Staff
Mentioned Staff
Sale of assets
Mentioned Sale of assets
Collection of receivables
Mentioned Collection of receivables
Security rights
Mentioned Security rights
Restart (going-concern sale)
Mentioned Restart (going-concern sale)
Bookkeeping obligation
Mentioned Bookkeeping obligation
Filing of annual accounts
Completed Filing of annual accounts
Director liability
Mentioned Director liability
Actio pauliana
Mentioned Actio pauliana
Legal proceedings
Mentioned Legal proceedings
Lawfulness investigation
Mentioned Lawfulness investigation

Timeline

  1. Bankruptcy declared

  2. Publication in the insolvency register

    Uitspraak faillissement op 04 maart 2025

  3. Public financial report of November 16, 2026 published

  4. Public report of November 16, 2026 published

Key documents

  • Financieel verslag 16-11-2026

    11-16-2026 9 p. Rechtspraak

    View
  • Verslag: 16-11-2026

    11-16-2026 20 p. Rechtspraak

    View
  • Uitspraak faillissement op 04 maart 2025

    03-05-2025 1 p. Central Insolvency Register

    View

Frequently asked questions about Caelus Pharmaceuticals B.V.

Who has been appointed bankruptcy trustee of Caelus Pharmaceuticals B.V.?

mr. J.F.H.M. Bartels of Labré Advocaten has been appointed bankruptcy trustee by the Rechtbank Amsterdam. The bankruptcy trustee is the point of contact for questions about the bankruptcy.

When was Caelus Pharmaceuticals B.V. declared bankrupt?

On March 4, 2025, Caelus Pharmaceuticals B.V. was declared bankrupt by the Rechtbank Amsterdam. The insolvency number of the case is F.13/25/78.

Where do I submit my claim against Caelus Pharmaceuticals B.V.?

Send your claim in writing to the insolvency practitioner, mr. J.F.H.M. Bartels of Labré Advocaten, with the documents that support it, such as invoices and contracts. Please state insolvency number F.13/25/78.

What does the bankruptcy of Caelus Pharmaceuticals B.V. mean for creditors?

Through the bankruptcy the company loses control of its assets. Control passes to the insolvency practitioner, who sells the assets and distributes the proceeds among the creditors in the statutory ranking. Only at the end is it usually clear whether ordinary creditors receive anything, and how much.

How do I read the reports on the bankruptcy?

The only public report so far appeared on November 16, 2026. It is under Reports in this case.

Company details

Legal form
BV

Sources

Not known: founded, kvk registration, trade names

Addresses

  • Business address Correspondence address Trading address
    Rondweg 50 3474 KG Zegveld
    municipality of Woerden Utrecht
    • Built in 1875
    • woonfunctie
    • 400 m²